Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 25;15(8):e44097.
doi: 10.7759/cureus.44097. eCollection 2023 Aug.

Orthostatic Hypotension in Benign Prostatic Hyperplasia Patients and Its Association With Alpha-1 Antagonist Use: A Comprehensive Literature Review

Muhammad Abubakar  1   2 , Rachna Prasad  3 , Siffat S Salim  4 , Deepak Basavaraju  5 , Munazza Khan  6 , Ibrahim K Lateef  6 , Ahmad Furqan  7 , Saud Raza  2 , Ishita Gupta  8 , Deepak Singla  9 , Hira Adil  10 , Ather Naeem  11
Affiliations
Review

Orthostatic Hypotension in Benign Prostatic Hyperplasia Patients and Its Association With Alpha-1 Antagonist Use: A Comprehensive Literature Review

Muhammad Abubakar et al. Cureus. .

Abstract

Orthostatic hypotension (OH) is frequently observed in benign prostatic hyperplasia (BPH) patients undergoing alpha-1 adrenergic antagonist (A1AA) therapy. While previous studies have acknowledged the prevalence of OH in BPH patients on A1AAs, limited data exist on ranking the safety of different A1AAs. This comprehensive review explores the underlying mechanisms of OH, examines numerous factors influencing its development, and provides insights into effective treatment strategies such as hydration, gradual postural changes, leg exercises, compression stockings, and tilt-table training for BPH management. The review highlights the significance of individualized care, interdisciplinary collaboration, and further research to optimize A1AA treatment, improve patient outcomes, and enhance quality of life.

Keywords: alpha-1 adrenergic antagonists; benign prostatic hyperplasia; lower urinary tract symptoms; orthostatic hypotension; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Benign prostatic hyperplasia: an overview. Roehrborn CG. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477638/ Rev Urol. 2005;7:0. - PMC - PubMed
    1. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group. Buzelin JM, Fonteyne E, Kontturi M, Witjes WP, Khan A. Br J Urol. 1997;80:597–605. - PubMed
    1. Biaggioni I, Kaufmann H. Encyclopedia of the Neurological Sciences (Second Edition) Cambridge, Massachusetts: Academic Press, Elsevier; 2014. Orthostatic Hypotension; pp. 698–700.
    1. Evaluating the impact of orthostatic syncope and presyncope on quality of life: a systematic review and meta-analysis. Hockin BCD, Heeney ND, Whitehurst DGT, Claydon VE. Front Cardiovasc Med. 2022;9:834879. - PMC - PubMed
    1. Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: a case report. Lee JY, Lee HS, Park SB, Lee KH. World J Clin Cases. 2022;10:9142–9147. - PMC - PubMed

LinkOut - more resources